Duane Reade Sale Reflects “Industry Issues”: Rx-To-OTC “Shifts” Cited
This article was originally published in The Tan Sheet
Market shift from Rx-to-OTC products is among pharmacy industry issues cited by the retail drug chain Duane Reade in explaining its decision to sell to the private equity firm Oak Hill Capital Partners
You may also be interested in...
Stronger than expected sales for OTC cold and flu remedies through the fall and early winter prompted Procter & Gamble to raise its fiscal second quarter sales and earnings forecast Jan. 7
The potential sale of the Eckerd drug store chain could set the stage for the first major expansion by a Canadian firm into the U.S. pharmacy business
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC